Single-strand selective monofunctional uracil-DNA glycosylase (SMUG1) deficiency is linked to aggressive breast cancer and predicts response to adjuvant therapy
Tarek M. Abdel-Fatah(Nottingham University Hospitals NHS Trust), Srinivasan Madhusudan(Nottingham University Hospitals NHS Trust), Claire Hawkes(University of Warwick), Paul M. Moseley(Nottingham University Hospitals NHS Trust), Lara Bowell(University of Nottingham), Nada Albarakati(University of Nottingham), Ian O. Ellis(University of Nottingham), Devika Agarwal(University of Oxford), Stephen Chan(Heidelberg University), Graham Ball(Computer Algorithms for Medicine)
Cited by 35
Related Papers
Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer
|New England Journal of Medicine|2010|4.5k
The somatic mutation profiles of 2,433 breast cancers refine their genomic and transcriptomic landscapes
|Nature Communications|2016|1.8k
The 2019 World Health Organization classification of tumours of the breast
|Histopathology|2020|1.1k
Prospective Randomized Trial of Docetaxel Versus Doxorubicin in Patients With Metastatic Breast Cancer
|Journal of Clinical Oncology|1999|639